David Coy Ross - 15 Jun 2025 Form 3 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Tech & Product Officer
Signature: /s/ Benjamin Landry, as Attorney-in-Fact
Issuer symbol: HCAT
Transactions as of: 15 Jun 2025
Transactions value $: $0
Form type: 3
Filing time: 25 Jun 2025, 16:49:38 UTC
Next filing: 04 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ross David Coy	Chief Tech & Product Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN	/s/ Benjamin Landry, as Attorney-in-Fact	25 Jun 2025	0002074748

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HCAT	Common Stock						625	15 Jun 2025	Direct	F1
holding	HCAT	Common Stock						1,125	15 Jun 2025	Direct	F2
holding	HCAT	Common Stock						1,875	15 Jun 2025	Direct	F3
holding	HCAT	Common Stock						10,937	15 Jun 2025	Direct	F2
holding	HCAT	Common Stock						21,875	15 Jun 2025	Direct	F4
holding	HCAT	Common Stock						90,000	15 Jun 2025	Direct	F5
holding	HCAT	Common Stock						81,142	15 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on September 1, 2022 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.
F2	Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on December 1, 2022 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.
F3	Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on September 1, 2023 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.
F4	Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on December 1, 2024 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.
F5	Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.